5 Most Promising Gene Editing Stocks According to Analysts

Page 5 of 5

1. Exact Sciences Corporation (NASDAQ:EXAS)

Number of Hedge Fund Holders: 39

One-Year Average Price Target: $73.65

Exact Sciences Corporation (NASDAQ:EXAS) is one of the most notable and promising stocks in the genomics space. Exact Sciences Corporation (NASDAQ:EXAS) is offering several solutions in related industries. The oncology-focused company is known for its The Oncotype DX® tests which deliver relevant genomic intelligence specific to the individual biology of a patient’s tumor. Back in 2019, Exact Sciences Corporation (NASDAQ:EXAS) completed its $2.8 billion acquisition of genomic diagnostics maker Genomic Health.

You can also take a peek at 15 Best Short-Term Stocks to Buy and 10 Best Stocks to Buy for High Returns.

Page 5 of 5